Medicine International,
Journal Year:
2024,
Volume and Issue:
5(2)
Published: Dec. 20, 2024
The
limitations
of
two‑dimensional
(2D)
models
in
cancer
research
have
hindered
progress
fully
understanding
the
complexities
drug
resistance
and
therapeutic
failures.
However,
three‑dimensional
(3D)
provide
a
more
accurate
representation
in
vivo
environments,
capturing
critical
cellular
interactions
dynamics
that
are
essential
evaluating
efficacy
toxicity
tyrosine
kinase
inhibitors
(TKIs).
These
advanced
enable
researchers
to
explore
mechanisms
with
greater
precision,
optimizing
treatment
strategies
improving
predictive
accuracy
clinical
outcomes.
By
leveraging
3D
models,
it
will
be
possible
deepen
current
TKIs
drive
forward
innovations
treatment.
present
review
discusses
2D
transformative
impact
on
oncology
research,
highlighting
their
roles
addressing
challenges
systems
advancing
TKI
studies.
Talanta Open,
Journal Year:
2024,
Volume and Issue:
9, P. 100297 - 100297
Published: Feb. 16, 2024
With
the
development
of
various
radiation-based
cancer
therapies,
radiobiological
evaluation
methods
instead
traditional
clonogenic
assays
with
monolayer
single
cell
culture
are
required
to
bridge
gaps
in
clinical
data.
Heterogeneity
within
tissues
is
reason
for
bridging
gap
between
basic
and
research
radiotherapy.
To
solve
this
problem,
we
investigated
an
assay
using
a
three-dimensional
(3D)
model
tissue.
In
study,
3D
consisting
tumor
stromal
layers
was
used
compare
verify
effects
conventional
two-dimensional
(2D)
methods.
A
significant
difference
response
radiation
observed
2D
models.
The
relative
number
cells
decreased
X-ray
dose
escalations
contrast,
normal
quite
different
Considering
ability
recover
from
radiation-induced
damage,
histological
results
were
reflected
Histopathological
analysis
potential
method
evaluating
on
margins.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
Abstract
Head
and
neck
squamous
cell
carcinoma
(HNSCC)
are
invasive
solid
tumors
accounting
for
high
mortality.
To
improve
the
clinical
outcome,
a
better
understanding
of
tumor
its
microenvironment
(TME)
is
crucial.
Three
‐dimensional
(3D)
bioprinting
emerging
as
powerful
tool
recreating
TME
in
vitro.
establish
long‐term
HNSCC
bioprinted
constructs
personalized
drug‐testing,
this
proof‐of‐principle
study
aims
to
compare
two
different
innovative
tunicate‐derived
nanocellulose
(NC)
hydrogels
against
widely
used
semi‐synthetic
gelatin
methacryloyl
(GelMA).
Cell
lines
origin
sites
printed
TEMPO
Carboxy‐NC,
GelMA
alginate
(GelMAA).
Both
NC
show
higher
bioprintability
than
GelMAA.
Carboxy‐NC
supported
survival,
proliferation,
maintenance
epithelial
phenotype
3D
similar
The
hydrogel
microstructure
revealed
differences
pore
size.
Importantly,
established
model
allowed
testing
radiochemotherapy
(RCT)
both
patient‐derived
cultures.
Compared
spheroid
model,
cytotoxic
effects
less,
reflecting
response
patients.
findings
indicate
that
viable
alternative
gelatin‐based
bioink
with
improved
allowing
drug‐testing.
By
adding
other
cell‐types
TME,
can
be
advanced
heterotypic
one.
The
development
of
engineered
cell
microenvironments
for
fundamental
mechanobiology,
in
vitro
disease
modeling,
and
tissue
engineering
applications
increased
exponentially
during
the
last
two
decades.
In
such
context,
radiobiology
is
a
field
research
aiming
at
understanding
effects
ionizing
radiation
(e.g.,
X-rays/photons,
high-speed
electrons,
protons)
on
biological
(cancerous)
tissues
cells,
particular
terms
DNA
damage
leading
to
death.
Herein,
perspective
provides
comparative
assessment
overview
scaffold-free,
scaffold-based,
organ-on-a-chip
models
radiobiology,
highlighting
opportunities,
limitations,
future
pathways
improve
currently
existing
approaches
toward
personalized
cancer
medicine.
Advanced Materials Technologies,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 12, 2025
Abstract
Despite
significant
advancements
in
oncology
research
and
therapeutic
interventions,
cancer
continues
to
be
the
leading
cause
of
mortality
worldwide.
The
key
challenge
addressing
this
pressing
issue
lies
lack
precision
diagnosis
a
limited
understanding
nature
how
tumor
microenvironment
responds
interventions.
Research
focusing
on
impact
(TME)
heterogeneity
response
drugs
is
crucial
ensure
efficient
therapy.
Conventional
models
exhibit
constraints,
including
inability
accurately
imitate
tumors’
complex
3D
architecture
dynamic
microenvironment.
Recent
developments
Spheroid‐On‐a‐Chip
(SoC)
technology
provide
alternative,
offering
closer
that
human
tissue.
This
review
explores
recent
SoC
modeling,
highlighting
spheroid
formation
mechanisms
techniques.
applications
platform
mimic
essential
features
their
potential
role
anticancer
drug
development
are
summarized.
advantages
challenges
technologies
behind
devices
compared
traditional
vitro
further
discussed.
Lastly,
future
directions
for
transforming
improving
suggested.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2582 - 2582
Published: July 18, 2024
Introduction:
Decellularized
extracellular
matrix
(ECM)
bioscaffolds
have
emerged
as
a
promising
three-dimensional
(3D)
model,
but
so
far
there
are
no
data
concerning
their
use
in
radiobiological
studies.
Material
and
Methods:
We
seeded
two
well-known
radioresistant
cell
lines
(HMV-II
PANC-1)
decellularized
porcine
liver-derived
scaffolds
irradiated
them
with
both
high-
(Carbon
Ions)
low-
(Photons)
Linear
Energy
Transfer
(LET)
radiation
order
to
test
whether
natural
3D-bioscaffold
might
be
useful
tool
for
research
achieve
an
evaluation
that
could
near
possible
what
happens
vivo.
Results:
Biological
provided
favorable
3D
environment
proliferation
expansion.
Cells
did
not
show
signs
of
dedifferentiation
retained
distinct
phenotype
coherently
anatomopathological
clinical
behaviors.
The
response
high
LET
was
higher
HMV-II
PANC-1
compared
the
low
LET.
In
particular,
Carbon
Ions
reduced
melanogenesis
induced
more
cytopathic
effects
substantial
deterioration
photons.
Conclusions:
addition
offering
suitable
model
appropriate
setting
preclinical
oncological
analysis,
we
can
attest
seemed
cost-effective
due
ease
use,
maintenance
requirements,
lack
complex
technology
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4436 - 4436
Published: May 7, 2025
Spatially
fractionated
radiotherapy
(SFRT)
offers
a
promising
approach
for
debulking
large
tumors
by
delivering
high-dose
radiation
to
fraction
of
the
tumor
volume.
However,
complex
microenvironment
necessitates
models
beyond
traditional
2D
cultures
and
resource-intensive
animal
studies
SFRT
investigations.
Three-dimensional
(3D)
scaffold-based
with
an
adequate
cross-sectional
area
have
emerged
as
uniquely
suited
platforms
bridge
this
gap,
providing
more
realistic
platform
GRID-based
research.
In
study,
we
employed
3D
co-culture
scaffold
model
dissect
contributions
radiation-induced
bystander
effect,
abscopal
immune
system
response
on
clonogenic
survival
following
GRID
irradiation.
MDA-MB-231
breast
cancer
cells
were
seeded
commercial
scaffolds
irradiated
at
20
Gy
peak
dose
using
lead
grids
three-
six-hole
patterns,
exposing
~12.8%
25.7%
area,
respectively.
An
assessment
reproductive
cell
revealed
significant
was
notably
lower
than
predicted
based
solely
directly
fraction.
Evidence
effect
observed
culturing
non-irradiated
in
media
exposed
Furthermore,
allogeneic
peripheral
blood
mononuclear
(PBMCs)
modulated
survival,
additive
when
combined
SFRT.
These
findings
underscore
presence
indicate
component,
particularly
three-hole
configuration.
This
study
established
utility
vitro
effective
elucidating
SFRT-mediated
biological
responses.
Annals of Medicine and Surgery,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 16, 2024
Introduction:
Approximately
50
million
people
worldwide
have
epilepsy,
with
many
not
achieving
seizure
freedom.
Organ-on-chip
technology,
which
mimics
organ-level
physiology,
could
revolutionize
drug
development
for
epilepsy
by
replacing
animal
models
in
preclinical
studies.
Our
goal
is
to
determine
if
customized
micro-physiological
systems
can
lead
tailored
treatments
epileptic
patients.
Materials
and
methods:
A
comprehensive
literature
search
was
conducted
utilizing
various
databases,
including
PubMed,
Ebscohost,
Medline,
the
National
Library
of
Medicine,
using
a
predetermined
strategy.
We
focused
on
articles
that
addressed
role
personalized
individual
responses
discussed
different
types
diagnosis,
current
treatment
options.
Additionally,
explored
components
design
considerations
were
reviewed
identify
challenges
opportunities
challenging
cases.
Results:
The
system
offers
more
accurate
cost-effective
alternative
traditional
assessing
effects,
toxicities,
disease
mechanisms.
Nevertheless,
designing
patient-specific
presents
critical
considerations,
integration
analytical
biosensors
patient-derived
cells,
while
addressing
regulatory,
material,
biological
complexities.
Material
selection,
standardization,
vascular
systems,
cost
efficiency,
real-time
monitoring,
ethical
are
also
crucial
successful
use
this
technology
development.
Conclusion:
future
organ-on-chip
holds
great
promise,
potential
integrate
artificial
intelligence
machine
learning
Cancers,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2515 - 2515
Published: July 11, 2024
Peptide
receptor
radionuclide
therapy
(PRRT)
using
177Lu-DOTA-TATE
has
recently
been
evaluated
for
the
treatment
of
meningioma
patients.
However,
current
knowledge
underlying
radiation
biology
is
limited,
in
part
due
to
lack
appropriate
vitro
models.
Here,
we
demonstrate
proof-of-concept
a
patient-derived
3D
culture
model
assess
short-term
response
therapies
such
as
PRRT
and
external
beam
radiotherapy
(EBRT).
We
established
cultures
(1
week)
16
meningiomas
with
high
efficiency
yield.
In
general,
spheroids
retained
characteristics
parental
tumor
during
initial
days
culturing.
For
subset
tumors,
clear
changes
towards
more
aggressive
phenotype
were
visible
over
time,
indicating
that
method
induced
dedifferentiation
cells.
To
efficacy,
demonstrated
specific
uptake
via
somatostatin
subtype
2
(SSTR2),
which
was
highly
overexpressed
majority
samples.
DNA
damage
detectable
an
extended
timeframe
compared
EBRT.
Interestingly,
levels
after
correlated
SSTR2-expression
tumors.
Our
can
be
used
EBRT
radiobiological
studies.
Further
improvement
this
should
pave
way
development
relevant
assessment
long-term
and,
potentially,
individual
patient
responses